Search This Blog

Thursday, July 30, 2026

Guardant beats, ups guidance

 

Guardant Health fiscal Q2 2026 revenue $335.0M (+44% YoY) beats estimates, EPS $-0.90 misses, 2026 guidance raised to $1.34–$1.36B

  • Non-GAAP EPS $-0.90 fell 12% YoY in fiscal Q2 2026, missing analyst expectations.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.